title: The emerging threat from carbapenem-resistant enterobacteriaceae.
abstract: The emergence of carbapenem-resistant enterobacteriaceae (CRE) in the United States represents a serious danger to people who are hospitalized and is associated with case mortality rates as high as 50 percent. CRE infections have limited treatment options and the potential to spread widely if prevention and transmission measures are not employed. Decreasing the impact of CRE requires coordinated efforts between nurses and other clinicians, as well as administrators, to improve patient outcomes.
authors.forename: Jessica
authors.initials: J
authors.lastname: Landry
authors.forename: Helen
authors.initials: H
authors.lastname: Hurst
mesh_terms: D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D015780:Carbapenems / Q000009:adverse effects* / Q000627:therapeutic use; D002487:Centers for Disease Control and Prevention, U.S.; D003428:Cross Infection / Q000188:drug therapy / Q000517:prevention & control / Q000635:transmission; D024881:Drug Resistance, Bacterial; D004755:Enterobacteriaceae / Q000187:drug effects; D004756:Enterobacteriaceae Infections / Q000188:drug therapy* / Q000517:prevention & control / Q000635:transmission; D063373:Hand Hygiene; D006801:Humans; D017053:Infection Control / Q000379:methods*; D017410:Practice Guidelines as Topic; D018570:Risk Assessment; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents; D015780:Carbapenems
keywords: CRE; carbapenem-resistant enterobacteriaceae; infection control; patient safety